A teenager was diagnosed with an aggressive tumor in the brain and was given from 12 to 18 months to live, monitored the first sign of the deadly disease in its eyes.
Joscelyne Kerr, 19, ended the school in 2023 when she noticed a change in her student.
The student expanded in her eyes to the point that the color was barely visible.
In June of that year, an optical specialist believed that it was a rare nervous disorder called Adie PuPil, but after her student became greater and began to experience a double vision, she was referred to NineWells Hospital in Dundee to perform a CT scan, and he was said to be a tumor.
“My father used to be an unprecedented anxiety doctor and anxiety in three types of people: a person with a stroke, drug addict and a dead person,” said Goslini, from Kenros in Scotland.
“Therefore, due to the lack of application of any of these, we did not think about it at the beginning until the aggravation of my two.
Read more about brain tumors
“Urgent MRI revealed what they believed was a Shuani tumor on the third eye nerve. This type of tumor is rare, but its presence on the sheath of the third in -kind nerve is more strange, with about 60 known cases only around the world.
“Initially, they thought it was a low -class tumor and was growing slowly for years, but with the change of symptoms every few weeks and getting worse, we insisted on sticking again soon.
“After celebrating my eighteenth birthday and starting my university session, we were shocked by finding that the tumor had doubled in size and was growing strongly.”
Brain tumors are the main cause of cancer -related deaths in children and adults under the age of 40.
According to brain tumor research, only 1 percent of national cancer research financing has been allocated to fight them since the start of records in 2002.
The charitable organization organized a month of events to highlight the effect of the disease, as the month of awareness of brain tumors represents the anniversary of 15 years.
Joscelyne’s tumor has begun to spread towards the brain’s stem, which was one day considered an area that is unable to work due to the risks.
It had two options: radiotherapy or highly dangerous surgery, aimed at removing it completely.
She chose surgery, and in December 2023, she underwent an operation that removed 90 percent of the tumor.
Due to complications, she suffered from memory loss and loss of muscle function, and she had to re -learn how to speak, read and write.
Four days later, she closed her body and could not respond to pain or movement.
In the end, she regained all jobs, but then got more bad news.
My ancestors had lived by the dark flavor before, so we refused to surrender
Jocelin Care
He said: “After the biopsy, the doctors diagnosed me with a very rare and cancerous tumor, with a diagnosis of 12 to 18 months.
“They were not sure whether an e-gBM or olive tumor (APXA) is, but they knew it was dangerous.
“Although 90 percent of them were removed, the rest – a crystallized mass – was wrapped around the arterial artery, the main supply of blood in my mind. It was destroyed, but my mother remained calm and told me,” It is just a number. “
She added: “I was told that I need to undergo chemotherapy and radiotherapy, and I think if this will be the last Christmas, then we will make it the best ever.”
She had six weeks of radiotherapy and chemotherapy in January 2024, but in March, the exams were revealed that both were ineffective, and the tumor was confirmed as AXPA, which is the only confirmed condition in Scotland.
Because of the branch of the tumor, the trial of Mrs. Kiir was determined Drugs Dabrafeenib and Treetinib, targeted cancer treatments used to treat solid tumors in small cells.
Follow -up examination showed Drugs The tumor decreased again to its condition.
Joscelyne and her family are now collecting money for a experimental property called DCVAX-L, which costs 250,000 pounds, hoping to save her life.
It is only tested on patients with glial tumor but appears as a promise on AXPA.
To date, I collected nearly 100,000 pounds.
She said: “The flow of love and generosity that I have gone through since all this happened.
“I also focus on increasing awareness of brain tumors, and it is exciting to see the new brain tumor research center that was recently opened in Edinburgh, near my university apartment.
“We strongly need more research in this disease because I think that the treatments that people receive are not always suitable, and they are only with research that is well funded that we can change this and save thousands of lives.
To support the Joscelyne donation campaign or donate its case, Click here.
The most common symptoms of the brain tumor

More than 12,000 Britons are diagnosed with a tumor in the basic brain every year – of which about half a cancerous – where 5300 loses their lives.
This disease is more deadly cancer in children and adults under the age of 40, according to the Association of brain tumor.
Brain tumors reduce the average life expectancy by 27 years, with only 12 percent of adults remaining after five years of diagnosis.
There are two main types, with non -cancerous benign tumors growing slower and less likely to return after treatment.
Cancer malignant brain tumors can start in the brain or spread there from another place of the body and are likely to return.
Brain tumors can cause headaches, seizures, nausea, vomiting and memory problems, according to NHS.
It can also lead to changes in personality weakness or paralysis on one side of the problem and speech problems or vision.
The most common symptoms are:
- Headache
- Seizures
- Feeling of disease
- To be sick
- Memory problems
- Change in the character
- Weakness or paralysis on one side of the body
- Vision problems
- Speech problems
If you suffer from any of these symptoms, especially headaches that seem different from those you usually get, you should visit your doctor.
Source: nhs